Regeneron Pharmaceuticals (REGN) Revenue by Segment

History

Date	Collaboration	Net Product	Other
Mar 31, 2025	6.32B	7.28B	480.00M
Dec 31, 2024	6.06B	7.63B	515.00M
Sep 30, 2024	5.82B	7.48B	548.10M
Jun 30, 2024	5.60B	7.32B	572.20M
Mar 31, 2024	5.39B	7.17B	537.00M
Dec 31, 2023	5.50B	7.08B	536.10M
Sep 30, 2023	5.72B	6.93B	451.30M
Jun 30, 2023	5.33B	6.94B	397.20M
Mar 31, 2023	5.06B	6.92B	387.10M
Dec 31, 2022	4.91B	6.89B	365.10M
Sep 30, 2022	4.22B	9.17B	323.60M
Jun 30, 2022	4.24B	9.65B	338.40M
Mar 31, 2022	4.15B	12.03B	325.20M
Dec 31, 2021	3.67B	12.12B	281.20M
Sep 30, 2021	3.46B	9.76B	318.40M
Jun 30, 2021	3.04B	8.97B	378.00M
Mar 31, 2021	2.60B	6.06B	543.80M
Dec 31, 2020	2.37B	5.57B	557.00M
Sep 30, 2020	2.18B	5.23B	529.10M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.